Advanced in Thrombocytopenia

Eleftheria Hatzimichael

St. Niarchou Av, 45 500 Ioannina, 
Ioannina, ESYE21, GR 
Advanced in Thrombocytopenia
St. Niarchou Av, 45 500 Ioannina, 
Ioannina, ESYE21, GR 
OverviewLocationsClinical Research

Overview

Eleftheria Hatzimichael practices in Ioannina, Greece. Ms. Hatzimichael is rated as an Advanced expert by MediFind in the treatment of Thrombocytopenia. Her top areas of expertise are Myelodysplastic Syndrome (MDS), Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Purpura, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 103 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Thrombocytopenia.

Gender
Female

Locations

St. Niarchou Av, 45 500 Ioannina, Ioannina, ESYE21, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Pomalidomide and Dexamethasone (B-Pd) Versus Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 8)
A Phase III, Multicenter, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Pomalidomide and Dexamethasone (B-Pd) Versus Pomalidomide Plus Bortezomib and Dexamethasone (PVd) in Participants With Relapsed/Refractory Multiple Myeloma (DREAMM 8)
Enrollment Status: Active_not_recruiting
Publish Date: March 18, 2025
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Pomalidomide, Dexamethasone, Bortezomib
Study Phase: Phase 3

103 Total Publications

Paroxysmal Nocturnal Hemoglobinuria: Unraveling Its Molecular Pathogenesis and Advancing Targeted Therapeutic Strategies.
Paroxysmal Nocturnal Hemoglobinuria: Unraveling Its Molecular Pathogenesis and Advancing Targeted Therapeutic Strategies.
Journal: Diseases (Basel, Switzerland)
Published: August 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hatzimichael's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 31 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile